Association of screening status, polygenic risk score and environmental risk factors with colorectal cancer incidence and mortality risks

被引:2
作者
Ren, Jiaojiao [1 ,2 ]
Zhang, Peidong [2 ,3 ]
Li, Zhihao [2 ]
Zhang, Xiru [2 ]
Shen, Dong [2 ]
Chen, Peiliang [2 ]
Huang, Qingmei [2 ]
Gao, Pingming [1 ,4 ]
Mao, Chen [2 ,5 ]
机构
[1] Southern Med Univ, Affiliated Foshan Matern & Child Healthcare Hosp, Foshan, Guangdong, Peoples R China
[2] Southern Med Univ, Sch Publ Hlth, Dept Epidemiol, Guangzhou, Guangdong, Peoples R China
[3] Southern Med Univ, Nanfang Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China
[4] Southern Med Univ, Sch Clin Med 2, Guangzhou, Guangdong, Peoples R China
[5] Southern Med Univ, Zhujiang Hosp, Microbiome Med Ctr, Dept Lab Med, Guangzhou, Guangdong, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
colorectal cancer; environmental risk factors; polygenic risk score; screening; HEALTHY LIFE-STYLE;
D O I
10.1002/ijc.34407
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Whether screening can attenuate the influence of genetic risk and environmental risk factors for colorectal cancer (CRC) mortality risk remains unknown. Our study is to investigate the association of the screening history, genetic risk and environmental risk factors with CRC incidence and mortality risks using UK Biobank data. Screening history was associated with lower CRC incidence (hazard ratio [HR]: 0.63, 95% confidence interval [CI]: 0.58-0.69) and mortality risk (HR: 0.56, 95% CI: 0.49-0.63). Compared to the HRs of participants with a low genetic risk, low environmental risk and no screening history, the HRs of participants with a high genetic risk, high environmental risk and no screening history were 3.42 (95% CI: 2.76-4.24) for CRC incidence and 3.36 (95% CI: 2.48-4.56) for CRC mortality. In contrast, the HRs of participants with a high genetic risk and no screening history, but a low environmental risk, were 1.92 (95% CI: 1.55-2.36) for CRC incidence and 1.88 (95% CI: 1.39-2.53) for CRC mortality. Furthermore, the HRs of participants with a high genetic risk and a low environmental risk, but a screening history were 1.62 (95% CI: 1.15-2.28) for CRC incidence and 1.77 (95% CI: 1.08-2.89) for CRC mortality. Participants benefited more substantially from screenings for CRC mortality than for CRC incidence risk. A higher environmental risk was associated with higher risk of CRC incidence and mortality within each category of genetic risk. These findings emphasize the importance of CRC screening and identifying environmental factors to reduce CRC incidence and mortality risks.
引用
收藏
页码:1778 / 1788
页数:11
相关论文
共 38 条
  • [1] Cumulative Burden of Colorectal Cancer Associated Genetic Variants Is More Strongly Associated With Early-Onset vs Late-Onset Cancer
    Archambault, Alexi N.
    Su, Yu-Ru
    Jeon, Jihyoun
    Thomas, Minta
    Lin, Yi
    Conti, David V.
    Win, Aung Ko
    Sakoda, Lori C.
    Lansdorp-Vogelaar, Iris
    Peterse, Elisabeth F. P.
    Zauber, Ann G.
    Duggan, David
    Holowatyj, Andreana N.
    Huyghe, Jeroen R.
    Brenner, Hermann
    Cotterchio, Michelle
    Bezieau, Stephane
    Schmit, Stephanie L.
    Edlund, Christopher K.
    Southey, Melissa C.
    MacInnis, Robert J.
    Campbell, Peter T.
    Chang-Claude, Jenny
    Slattery, Martha L.
    Chan, Andrew T.
    Joshi, Amit D.
    Song, Mingyang
    Cao, Yin
    Woods, Michael O.
    White, Emily
    Weinstein, Stephanie J.
    Ulrich, Cornelia M.
    Hoffmeister, Michael
    Bien, Stephanie A.
    Harrison, Tabitha A.
    Hampe, Jochen
    Li, Christopher I.
    Schafmayer, Clemens
    Offit, Kenneth
    Pharoah, Paul D.
    Moreno, Victor
    Lindblom, Annika
    Wolk, Alicja
    Wu, Anna H.
    Li, Li
    Gunter, Marc J.
    Gsur, Andrea
    Keku, Temitope O.
    Pearlman, Rachel
    Bishop, D. Timothy
    [J]. GASTROENTEROLOGY, 2020, 158 (05) : 1274 - +
  • [2] Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies
    Brenner, Hermann
    Stock, Christian
    Hoffmeister, Michael
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
  • [3] Reduced Risk of Colorectal Cancer Up to 10 Years After Screening, Surveillance, or Diagnostic Colonoscopy
    Brenner, Hermann
    Chang-Claude, Jenny
    Jansen, Lina
    Knebel, Phillip
    Stock, Christian
    Hoffmeister, Michael
    [J]. GASTROENTEROLOGY, 2014, 146 (03) : 709 - 717
  • [4] An Update on the Epidemiology, Molecular Characterization, Diagnosis, and Screening Strategies for Early-Onset Colorectal Cancer
    Burnett-Hartman, Andrea N.
    Lee, Jeffrey K.
    Demb, Joshua
    Gupta, Samir
    [J]. GASTROENTEROLOGY, 2021, 160 (04) : 1041 - 1049
  • [5] The UK Biobank resource with deep phenotyping and genomic data
    Bycroft, Clare
    Freeman, Colin
    Petkova, Desislava
    Band, Gavin
    Elliott, Lloyd T.
    Sharp, Kevin
    Motyer, Allan
    Vukcevic, Damjan
    Delaneau, Olivier
    O'Connell, Jared
    Cortes, Adrian
    Welsh, Samantha
    Young, Alan
    Effingham, Mark
    McVean, Gil
    Leslie, Stephen
    Allen, Naomi
    Donnelly, Peter
    Marchini, Jonathan
    [J]. NATURE, 2018, 562 (7726) : 203 - +
  • [6] Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study
    Cardoso, Rafael
    Guo, Feng
    Heisser, Thomas
    Hackl, Monika
    Ihle, Petra
    De Schutter, Harlinde
    Van Damme, Nancy
    Valerianova, Zdravka
    Atanasov, Trajan
    Majek, Ondrej
    Muzik, Jan
    Nilbert, Mef Christina
    Tybjerg, Anne Julie
    Innos, Kaire
    Magi, Margit
    Malila, Nea
    Bouvier, Anne-Marie
    Bouvier, Veronique
    Launoy, Guy
    Woronoff, Anne-Sophie
    Cariou, Melanie
    Robaszkiewicz, Michel
    Delafosse, Patricia
    Poncet, Florence
    Katalinic, Alexander
    Walsh, Paul M.
    Senore, Carlo
    Rosso, Stefano
    Vincerzevskiene, Ieva
    Lemmens, Valery E. P. P.
    Elferink, Marloes A. G.
    Johannesen, Tom Borge
    Korner, Hartwig
    Pfeffer, Frank
    Bento, Maria Jose
    Rodrigues, Jessica
    da Costa, Filipa Alves
    Miranda, Ana
    Zadnik, Vesna
    Zagar, Tina
    de Munain Marques, Arantza Lopez
    Marcos-Gragera, Rafael
    Puigdemont, Montse
    Galceran, Jaume
    Carulla, Maria
    Chirlaque, Maria-Dolores
    Ballesta, Monica
    Sundquist, Kristina
    Sundquist, Jan
    Weber, Marco
    [J]. LANCET ONCOLOGY, 2021, 22 (07) : 1002 - 1013
  • [7] Estimation of Absolute Risk of Colorectal Cancer Based on Healthy Lifestyle, Genetic Risk, and Colonoscopy Status in a Population-Based Study
    Carr, Prudence R.
    Weigl, Korbinian
    Edelmann, Dominic
    Jansen, Lina
    Chang-Claude, Jenny
    Brenner, Hermann
    Hoffmeister, Michael
    [J]. GASTROENTEROLOGY, 2020, 159 (01) : 129 - +
  • [8] Healthy Lifestyle Factors Associated With Lower Risk of Colorectal Cancer Irrespective of Genetic Risk
    Carr, Prudence R.
    Weigl, Korbinian
    Jansen, Lina
    Walter, Viola
    Erben, Vanessa
    Chang-Claude, Jenny
    Brenner, Hermann
    Hoffmeister, Michael
    [J]. GASTROENTEROLOGY, 2018, 155 (06) : 1805 - +
  • [9] Non-steroidal anti-inflammatory drugs, polygenic risk score and colorectal cancer risk
    Chen, Xuechen
    Guo, Feng
    Hoffmeister, Michael
    Chang-Claude, Jenny
    Brenner, Hermann
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (02) : 167 - 175
  • [10] Effects of Screenings in Reducing Colorectal Cancer Incidence and Mortality Differ by Polygenic Risk Scores
    Choi, Jungyoon
    Jia, Guochong
    Wen, Wanqing
    Long, Jirong
    Shu, Xiao-Ou
    Zheng, Wei
    [J]. CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2021, 12 (05) : E00344